F-star Therapeutics Overview

F-star Therapeutics Operating Income

Operating Income for FSTX.

Quarterly Operating Income

$-13706000.00

↑ 42.76% YoY

As of Sep 30, 2022

Annual Operating Income (TTM)

$-36896000.00

↓ 16.71% YoY

Trailing 12 months ending Sep 30, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin